Prednisone NDC 61919-365

NDC codes

FDA NDC Directory

Product NDC (as listed)61919-365Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61919-0365Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
61919-365-21	61919036521	21 TABLET in 1 DOSE PACK (61919-365-21)Marketed from Jan 1, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prednisone
Generic name (nonproprietary): prednisone
Active ingredients: Prednisone — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: DIRECT RX
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040584
Marketing start: Jan 1, 2014
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 61919-365_4d3fa8d2-31a1-759a-e063-6294a90a0267SPL ID 4d3fa8d2-31a1-759a-e063-6294a90a0267SPL set ID 2a053775-6f6a-455e-b9a8-8b60e6062db3RxCUI 312617, 763181UNII VB0R961HZT
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N461919036521 followed by a unit qualifier and the quantity

Package 61919-0365-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 17, 2026.

Indications (excerpt from the label)

INDICATIONS & USAGE Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance)Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with canceR 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) Ankylosing spondylitis Acu…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040584

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040584
Product	Strength	Form · route	Labeler	Product NDC
Prednisone	Prednisone 1 mg/1	TabletOral	Par Health USA, LLC	0603-5335
Prednisone	Prednisone 1 mg/1	TabletOral	Bryant Ranch Prepack	71335-3129
Prednisone	Prednisone 1 mg/1	TabletOral	Bryant Ranch Prepack	63629-2254
Prednisone	Prednisone 1 mg/1	TabletOral	Bryant Ranch Prepack	72162-1169